N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one

C121H170N48O5S — CID 160688717

IUPACN,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one
SMILESCC(C)C1=NN=C2C(N)=CC=NC21.CC(C)c1nnc2c(=O)[nH]ccn12.CC(C)n1cnc2c(N(C)C)ccnc21.CC(C)n1cnc2c(NCCO)ccnc21.CCCNc1ccc2ncn(C(C)C)c2n1.CCCNc1ccnc2c1ncn2C(C)C.CCOc1nc(C)nc2c1ncn2C(C)C.CNc1ncc2ncn(C(C)C)c2n1.COc1ccnc2c1ncn2C(C)C.CSc1ccnc2c1ncn2C(C)C.Cc1nc(N)c2ncn(C(C)C)c2n1.Cc1nc2c(ncn2C(C)C)c(=O)[nH]1
InChIInChI=1S/2C12H18N4.2C11H16N4O.C11H16N4.C10H13N3O.C10H13N3S.2C9H13N5.C9H12N4O.C9H12N4.C8H10N4O/c1-4-7-13-11-6-5-10-12(15-11)16(8-14-10)9(2)3;1-4-6-13-10-5-7-14-12-11(10)15-8-16(12)9(2)3;1-5-16-11-9-10(13-8(4)14-11)15(6-12-9)7(2)3;1-8(2)15-7-14-10-9(12-5-6-16)3-4-13-11(10)15;1-8(2)15-7-13-10-9(14(3)4)5-6-12-11(10)15;2*1-7(2)13-6-12-9-8(14-3)4-5-11-10(9)13;1-6(2)14-5-12-7-4-11-9(10-3)13-8(7)14;1-5(2)14-4-11-7-8(10)12-6(3)13-9(7)14;1-5(2)13-4-10-7-8(13)11-6(3)12-9(7)14;1-5(2)7-9-8(13-12-7)6(10)3-4-11-9;1-5(2)6-10-11-7-8(13)9-3-4-12(6)7/h5-6,8-9H,4,7H2,1-3H3,(H,13,15);5,7-9H,4,6H2,1-3H3,(H,13,14);6-7H,5H2,1-4H3;3-4,7-8,16H,5-6H2,1-2H3,(H,12,13);5-8H,1-4H3;2*4-7H,1-3H3;4-6H,1-3H3,(H,10,11,13);4-5H,1-3H3,(H2,10,12,13);4-5H,1-3H3,(H,11,12,14);3-5,9H,10H2,1-2H3;3-5H,1-2H3,(H,9,13)
InChIKeyRPCXRUPSLGBDAG-UHFFFAOYSA-N
MW2409.09 g/mol
LogP21.08
Rot. Bonds27

About N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one

N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one (PubChem CID 160688717) has the molecular formula C121H170N48O5S and a molecular weight of 2409.09 g/mol. Its IUPAC name is N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one.

Molecular Properties

Compound NameN,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one
PubChem CID160688717
Molecular FormulaC121H170N48O5S
Molecular Weight2409.09 g/mol
Exact Mass2407.42
IUPAC NameN,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one
SMILESCC(C)C1=NN=C2C(N)=CC=NC21.CC(C)c1nnc2c(=O)[nH]ccn12.CC(C)n1cnc2c(N(C)C)ccnc21.CC(C)n1cnc2c(NCCO)ccnc21.CCCNc1ccc2ncn(C(C)C)c2n1.CCCNc1ccnc2c1ncn2C(C)C.CCOc1nc(C)nc2c1ncn2C(C)C.CNc1ncc2ncn(C(C)C)c2n1.COc1ccnc2c1ncn2C(C)C.CSc1ccnc2c1ncn2C(C)C.Cc1nc(N)c2ncn(C(C)C)c2n1.Cc1nc2c(ncn2C(C)C)c(=O)[nH]1
InChIInChI=1S/2C12H18N4.2C11H16N4O.C11H16N4.C10H13N3O.C10H13N3S.2C9H13N5.C9H12N4O.C9H12N4.C8H10N4O/c1-4-7-13-11-6-5-10-12(15-11)16(8-14-10)9(2)3;1-4-6-13-10-5-7-14-12-11(10)15-8-16(12)9(2)3;1-5-16-11-9-10(13-8(4)14-11)15(6-12-9)7(2)3;1-8(2)15-7-14-10-9(12-5-6-16)3-4-13-11(10)15;1-8(2)15-7-13-10-9(14(3)4)5-6-12-11(10)15;2*1-7(2)13-6-12-9-8(14-3)4-5-11-10(9)13;1-6(2)14-5-12-7-4-11-9(10-3)13-8(7)14;1-5(2)14-4-11-7-8(10)12-6(3)13-9(7)14;1-5(2)13-4-10-7-8(13)11-6(3)12-9(7)14;1-5(2)7-9-8(13-12-7)6(10)3-4-11-9;1-5(2)6-10-11-7-8(13)9-3-4-12(6)7/h5-6,8-9H,4,7H2,1-3H3,(H,13,15);5,7-9H,4,6H2,1-3H3,(H,13,14);6-7H,5H2,1-4H3;3-4,7-8,16H,5-6H2,1-2H3,(H,12,13);5-8H,1-4H3;2*4-7H,1-3H3;4-6H,1-3H3,(H,10,11,13);4-5H,1-3H3,(H2,10,12,13);4-5H,1-3H3,(H,11,12,14);3-5,9H,10H2,1-2H3;3-5H,1-2H3,(H,9,13)
InChIKeyRPCXRUPSLGBDAG-UHFFFAOYSA-N
XLogP21.08
TPSA620.85 Ų
H-Bond Donors9
H-Bond Acceptors52
Rotatable Bonds27
Heavy Atoms175
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002409.09
LogP ≤ 521.08
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1052

Analyze N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one?
The IUPAC name of N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one (CID 160688717) is N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one.
What is the SMILES notation for N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one?
The canonical SMILES for N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one is CC(C)C1=NN=C2C(N)=CC=NC21.CC(C)c1nnc2c(=O)[nH]ccn12.CC(C)n1cnc2c(N(C)C)ccnc21.CC(C)n1cnc2c(NCCO)ccnc21.CCCNc1ccc2ncn(C(C)C)c2n1.CCCNc1ccnc2c1ncn2C(C)C.CCOc1nc(C)nc2c1ncn2C(C)C.CNc1ncc2ncn(C(C)C)c2n1.COc1ccnc2c1ncn2C(C)C.CSc1ccnc2c1ncn2C(C)C.Cc1nc(N)c2ncn(C(C)C)c2n1.Cc1nc2c(ncn2C(C)C)c(=O)[nH]1.
What is the InChIKey of N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one?
The InChIKey is RPCXRUPSLGBDAG-UHFFFAOYSA-N. The full InChI is InChI=1S/2C12H18N4.2C11H16N4O.C11H16N4.C10H13N3O.C10H13N3S.2C9H13N5.C9H12N4O.C9H12N4.C8H10N4O/c1-4-7-13-11-6-5-10-12(15-11)16(8-14-10)9(2)3;1-4-6-13-10-5-7-14-12-11(10)15-8-16(12)9(2)3;1-5-16-11-9-10(13-8(4)14-11)15(6-12-9)7(2)3;1-8(2)15-7-14-10-9(12-5-6-16)3-4-13-11(10)15;1-8(2)15-7-13-10-9(14(3)4)5-6-12-11(10)15;2*1-7(2)13-6-12-9-8(14-3)4-5-11-10(9)13;1-6(2)14-5-12-7-4-11-9(10-3)13-8(7)14;1-5(2)14-4-11-7-8(10)12-6(3)13-9(7)14;1-5(2)13-4-10-7-8(13)11-6(3)12-9(7)14;1-5(2)7-9-8(13-12-7)6(10)3-4-11-9;1-5(2)6-10-11-7-8(13)9-3-4-12(6)7/h5-6,8-9H,4,7H2,1-3H3,(H,13,15);5,7-9H,4,6H2,1-3H3,(H,13,14);6-7H,5H2,1-4H3;3-4,7-8,16H,5-6H2,1-2H3,(H,12,13);5-8H,1-4H3;2*4-7H,1-3H3;4-6H,1-3H3,(H,10,11,13);4-5H,1-3H3,(H2,10,12,13);4-5H,1-3H3,(H,11,12,14);3-5,9H,10H2,1-2H3;3-5H,1-2H3,(H,9,13).
What are the key properties of N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one?
N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one has a molecular weight of 2409.09 g/mol, XLogP of 21.08, 27 rotatable bonds, 9 hydrogen bond donors, and 52 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-3-propan-2-ylimidazo[4,5-b]pyridin-7-amine;6-ethoxy-2-methyl-9-propan-2-ylpurine;7-methoxy-3-propan-2-ylimidazo[4,5-b]pyridine;2-methyl-9-propan-2-ylpurin-6-amine;N-methyl-9-propan-2-ylpurin-2-amine;2-methyl-9-propan-2-yl-1H-purin-6-one;7-methylsulfanyl-3-propan-2-ylimidazo[4,5-b]pyridine;3-propan-2-yl-3aH-pyrazolo[4,3-b]pyridin-7-amine;2-[(3-propan-2-ylimidazo[4,5-b]pyridin-7-yl)amino]ethanol;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-5-amine;3-propan-2-yl-N-propylimidazo[4,5-b]pyridin-7-amine;3-propan-2-yl-7H-[1,2,4]triazolo[4,3-a]pyrazin-8-one is sourced from PubChem (CID 160688717), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).